Nazem and Company
1
8M
1
0.02
1
- Stages of investment
- Areas of investment
Summary
Nazem and Company appeared to be the VC, which was created in 1976. The company was established in North America in United States. The main office of represented VC is situated in the New York.
The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2013. The high activity for fund was in 2004. The common things for fund are deals in the range of 5 - 10 millions dollars.
Among the most popular portfolio startups of the fund, we may highlight Bluebird Bio. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Pharmaceutical.
The usual cause for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are ABN AMRO Fund. In the next rounds fund is usually obtained by Easton Capital, Third Rock Ventures, Techno Venture Management.
The current fund was established by Fred Nazem. Besides them, we counted 1 critical employee of this fund in our database.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.02
- Investments by industry
- Pharmaceutical (1)
- Biotechnology (1)
- Health Diagnostics (1)
- Genetics (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2004
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 28
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Bluebird Bio | 17 Jun 2004 | Biotechnology, Health Diagnostics, Genetics, Pharmaceutical | Early Stage Venture | 8M | United States, Massachusetts, Cambridge |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.